Clinical Trial Update: Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluating maintenance therapy with oral azacitidine plus best supportive care in adults with acute myeloid leukemia who are in complete r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Oral azacitidine (azacitidine (oral formulation))

Snippet

Sponsor: Celgene | Conditions: Leukemia, Myeloid, Acute | Phase 3 | Status: COMPLETED | Results posted: 2020-11-06